NCT00916760View on ClinicalTrials.gov

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Allergic Rhinoconjunctivitis
Interventions
BIOLOGICAL

Depigoid Parietaria judaica 1000DPP/ml

Subcutaneous monthly treatment

BIOLOGICAL

Placebo

Subcutaneous monthly treatment

Trial Locations (11)

46520

H. de sagunto, Sagunto

08916

H. Germans Trias i Pujol, Badalona

08840

Hospital Viladecans, Barcelona

03314

Hospital Vega Baja, Alicante

Unknown

Hospital General de Onteniente, Ontinyent

Hospital Luis Alcañiz, Xàtiva

Hospital Marina Baixa, Alicante

Hospital de Castellón, Castellon

Hospital Reina Sofía, Murcia

Hospital Virgen de la Arrixaca, Murcia

Hospital La Fe, Valencia

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT00916760 - Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica | Biotech Hunter | Biotech Hunter